Schoretsanitis, Georgios; Stegmann, Benedikt; Hiemke, Christoph; Gründer, Gerhard; Schruers, Koen R J; Walther, Sebastian; Lammertz, Sarah E; Haen, Ekkehard; Paulzen, Michael (2016). Pharmacokinetic patterns of risperidone-associated adverse drug reactions. European journal of clinical pharmacology, 72(9), pp. 1091-1098. Springer 10.1007/s00228-016-2085-2
|
Text
art%3A10.1007%2Fs00228-016-2085-2.pdf - Published Version Available under License Publisher holds Copyright. Download (340kB) | Preview |
PURPOSE
The aim of the study was to investigate a correlation between plasma concentrations of risperidone (RIS), its active metabolite 9-hydroxyrisperidone (9-OH-RIS) and the active moiety (AM) (RIS + 9-OH-RIS), and adverse drug reactions (ADRs) in a naturalistic sample.
METHODS
Plasma concentrations of RIS, 9-OH-RIS, and AM in patients out of a therapeutic drug monitoring (TDM) database complaining ADRs were categorized according to the Udvalg for Kliniske Undersogelser side effect rating scales (UKU) (n = 97) and compared to patients without ADRs (n = 398).
RESULTS
Patients in the ADR group received a significantly lower daily dosage of risperidone (trimmed mean 3.64 mg/day) than patients without ADRs (4.40 mg/day). No differences were found for active moiety plasma concentrations between the groups (p = 0.454). Differences were detected only in the case of dose-adjusted plasma concentration values (concentration-by-dose, C/D) for 9-OH-RIS, being higher in patients reporting ADRs (4.78 ng/mL/mg) than in patients without ADRs (4.3 ng/mL/mg) (p = 0.037 for Mann-Whitney U test). Note that differences for non-adjusted 9-OH-RIS plasma levels between groups failed to reach significance (p = 0.697).
CONCLUSIONS
Our findings are consistent with previous data supporting a prominent role of 9-hydroxyrisperidone, but not of risperidone with regard to ADRs. When studying the various subgroups of reported ADRs separately, the size of these subsamples offers some plausible limitations by reducing the power of the analysis.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Translational Research Center 04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Management 04 Faculty of Medicine > University Psychiatric Services |
UniBE Contributor: |
Schoretsanitis, Georgios, Walther, Sebastian |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0031-6970 |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Sebastian Walther |
Date Deposited: |
29 Aug 2016 09:46 |
Last Modified: |
05 Dec 2022 14:57 |
Publisher DOI: |
10.1007/s00228-016-2085-2 |
PubMed ID: |
27376639 |
Uncontrolled Keywords: |
Antipsychotics; Drug metabolism; Pharmacokinetics; Psychopharmacology; Schizophrenia |
BORIS DOI: |
10.7892/boris.86082 |
URI: |
https://boris.unibe.ch/id/eprint/86082 |
Actions (login required)
 |
Edit item |